WuXi AppTec Co., Ltd. (WUXIF)
USD 7.12
(0.0%)
USD 7.12
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -8.01 Billion CNY | -278.26% |
| 2022 | -2.11 Billion CNY | 46.41% |
| 2021 | -3.95 Billion CNY | 33.46% |
| 2020 | -5.94 Billion CNY | -1372.4% |
| 2019 | 467.11 Million CNY | 110.16% |
| 2018 | -4.59 Billion CNY | -449.41% |
| 2017 | -837.22 Million CNY | 58.52% |
| 2016 | -2.01 Billion CNY | -143.11% |
| 2015 | -830.25 Million CNY | -319.75% |
| 2014 | 377.81 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -8.63 Billion CNY | -7.67% |
| 2024 Q3 | -8.43 Billion CNY | 3.64% |
| 2024 Q2 | -7.5 Billion CNY | 13.04% |
| 2023 Q2 | -3.9 Billion CNY | 5.66% |
| 2023 Q1 | -4.14 Billion CNY | -95.35% |
| 2023 FY | -8.01 Billion CNY | -278.26% |
| 2023 Q4 | -8.01 Billion CNY | -151.47% |
| 2023 Q3 | -3.18 Billion CNY | 18.39% |
| 2022 Q3 | -3.72 Billion CNY | -72.49% |
| 2022 Q1 | -2.24 Billion CNY | 43.17% |
| 2022 FY | -2.11 Billion CNY | 46.41% |
| 2022 Q4 | -2.11 Billion CNY | 43.15% |
| 2022 Q2 | -2.16 Billion CNY | 3.84% |
| 2021 Q4 | -3.95 Billion CNY | 2.29% |
| 2021 FY | -3.95 Billion CNY | 33.46% |
| 2021 Q1 | -6.6 Billion CNY | -11.07% |
| 2021 Q2 | -5.37 Billion CNY | 18.64% |
| 2021 Q3 | -4.04 Billion CNY | 24.64% |
| 2020 Q4 | -5.94 Billion CNY | 32.29% |
| 2020 Q3 | -8.77 Billion CNY | -430.09% |
| 2020 Q2 | 2.65 Billion CNY | 1172.02% |
| 2020 Q1 | 209.04 Million CNY | -55.25% |
| 2020 FY | -5.94 Billion CNY | -1372.4% |
| 2019 Q3 | 304.9 Million CNY | 119.65% |
| 2019 FY | 467.11 Million CNY | 110.16% |
| 2019 Q4 | 467.11 Million CNY | 53.2% |
| 2019 Q2 | -1.55 Billion CNY | 60.57% |
| 2019 Q1 | -3.93 Billion CNY | 14.44% |
| 2018 Q4 | -4.59 Billion CNY | -479.44% |
| 2018 FY | -4.59 Billion CNY | -449.41% |
| 2018 Q3 | 1.21 Billion CNY | 100.97% |
| 2018 Q2 | 603.19 Million CNY | 403.18% |
| 2018 Q1 | 119.87 Million CNY | 114.32% |
| 2017 FY | -837.22 Million CNY | 58.52% |
| 2017 Q3 | 64.51 Million CNY | 0.0% |
| 2017 Q4 | -837.22 Million CNY | -1397.72% |
| 2017 Q1 | -1.15 Billion CNY | 0.0% |
| 2016 FY | -2.01 Billion CNY | -143.11% |
| 2015 FY | -830.25 Million CNY | -319.75% |
| 2014 FY | 377.81 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.2 Million USD | 363490.425% |
| Arrayit Corporation | 1.05 Million USD | 759530.15% |
| Atlantic International Corp. | 236.49 Thousand USD | 3389752.585% |
| Biocept, Inc. | -788 Thousand USD | -1017208.728% |
| Bioqual, Inc. | -12 Million USD | -66663.743% |
| CardioGenics Holdings Inc | 22.73 Thousand USD | 35254037.187% |
| DermTech, Inc. | 17.65 Million USD | 45510.937% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | -572.49 Million USD | -1300.264% |
| HTG Molecular Diagnostics, Inc. | -7.37 Million USD | -108568.723% |
| iMD Companies, Inc. | 1.11 Million USD | 718470.123% |
| IDenta Corp. | 524.85 Thousand USD | 1527462.528% |
| Interpace Biosciences, Inc. | 7.69 Million USD | 104290.184% |
| Integrative Health Technologies, Inc. | -26.95 Thousand USD | -29743120.455% |
| InVitro International | -313.14 Thousand USD | -2559886.452% |
| Lumos Diagnostics Holdings Limited | 1.56 Million USD | 512030.59% |
| Many Bright Ideas Technologies Inc. | -713.00 USD | -1124318662.553% |
| Medical Imaging Corp. | 3.79 Million USD | 211562.153% |
| NovelStem International Corp. | 3.52 Million USD | 227739.098% |
| Optigenex Inc. | 8.93 Million USD | 89829.265% |
| PharmChem, Inc. | -1.49 Million USD | -536324.186% |
| Proteome Sciences plc | 14.57 Million USD | 55107.38% |
| Response Genetics, Inc | -13.08 Million USD | -61159.306% |
| Rennova Health, Inc. | 14.82 Million USD | 54155.693% |
| RushNet, Inc. | 4.8 Million USD | 167078.788% |
| ScreenPro Security Inc. | 135.58 Thousand USD | 5912373.693% |
| Stella Diagnostics Inc. | 6.19 Million USD | 129541.57% |
| StageZero Life Sciences Ltd. | 1.78 Million USD | 449348.894% |
| Todos Medical Ltd. | 38.31 Million USD | 21022.881% |